+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Minimally Invasive Glaucoma Surgery Devices Market - Global Forecast 2026-2032- Product Image
Minimally Invasive Glaucoma Surgery Devices Market - Global Forecast 2026-2032- Product Image
Sale

Minimally Invasive Glaucoma Surgery Devices Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968801
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Minimally Invasive Glaucoma Surgery Devices Market is projected to reach USD 671.86 Million in 2026. It is expected to continue growing at a CAGR of 5.82%, reaching USD 944.80 Million by 2032.

Minimally invasive glaucoma surgery devices are reshaping glaucoma management by offering a lower-trauma surgical option between topical medication, laser therapy, and conventional trabeculectomy or tube shunt surgery. The clinical need is substantial: peer-reviewed epidemiology estimates that approximately 76 million people aged 40 to 80 had glaucoma in 2020, with prevalence projected to reach 111.8 million by 2040.

MIGS adoption is supported by aging populations, rising cataract surgery volumes, and demand for procedures that can reduce intraocular pressure and medication burden while preserving safety. Growth in clinical use is strongest where ophthalmologists have access to reimbursed devices, modern ambulatory surgery infrastructure, optical coherence tomography, gonioscopy-based surgical training, and longitudinal glaucoma monitoring.

Transformative Shifts Reshaping MIGS Adoption

The MIGS landscape is moving from a cataract-combination niche toward broader procedural glaucoma care. Trabecular micro-bypass stents, canaloplasty systems, goniotomy devices, subconjunctival implants, and suprachoroidal approaches are competing on durability, safety profile, ease of implantation, and fit within ophthalmic surgery workflows.

Key shifts include earlier intervention in mild-to-moderate open-angle glaucoma, greater attention to medication adherence challenges, and stronger post-market evidence requirements. Regulatory scrutiny, surgeon training, reimbursement coding, and comparative outcomes versus selective laser trabeculoplasty and conventional filtration surgery are now central to commercial success in the minimally invasive glaucoma surgery devices landscape.

Cumulative Impact of AI on Glaucoma Surgery Pathways

Artificial intelligence is increasingly cumulative across the glaucoma care pathway rather than limited to device design. AI-enabled analysis of OCT, fundus imaging, visual fields, and electronic health records can support risk stratification, progression detection, referral prioritization, and selection of patients who may benefit from minimally invasive glaucoma surgery.

AI also improves operational efficiency by helping clinics manage follow-up intervals and identify nonadherence risk. However, adoption depends on validated datasets, explainability, cybersecurity, and regulatory compliance. In MIGS, the near-term impact is strongest in diagnostics, surgical planning, outcomes tracking, real-world evidence generation, and post-procedure monitoring of intraocular pressure control.

Regional Dynamics Across Global MIGS Markets

North America remains a leading region for minimally invasive glaucoma surgery device commercialization due to FDA-cleared technologies, high cataract procedure volumes, glaucoma subspecialty networks, and established ambulatory surgery centers in the United States and Canada. Europe benefits from advanced ophthalmology infrastructure across major health systems, while the Medical Device Regulation has increased requirements for clinical evidence, post-market surveillance, and technical documentation.

Asia-Pacific offers major long-term clinical potential because glaucoma prevalence rises with aging, urbanization, diabetes comorbidity, and expanding eye-care access in China, India, Japan, South Korea, and Australia. Japan, Australia, and South Korea support advanced ophthalmic procedures through specialist capacity and structured health systems, while China and India combine large glaucoma populations with expanding private and public eye-care networks.

Latin America, the Middle East, and Africa show demand linked to unmet glaucoma diagnosis and treatment needs, but affordability, specialist density, surgical training access, and reimbursement variability shape adoption speed. Brazil and Mexico anchor Latin American uptake through private ophthalmology centers; GCC countries in the Middle East benefit from investment in tertiary hospitals; and Africa’s adoption is constrained by late diagnosis, limited glaucoma specialist availability, and uneven access to surgical infrastructure.

Group-Level Demand Patterns and Policy Signals

The European Union is defined by harmonized but more rigorous device regulation, favoring manufacturers with strong clinical evidence, quality systems, and post-market surveillance. G7 markets concentrate premium ophthalmic spending, surgeon training capacity, established cataract surgery workflows, and early adoption of data-driven glaucoma care, making evidence quality and reimbursement alignment decisive for minimally invasive glaucoma surgery device uptake.

BRICS countries represent large patient pools and expanding private ophthalmology networks, especially in China, India, and Brazil, while Russia is more affected by procurement limitations and geopolitical constraints. ASEAN markets are heterogeneous, with Singapore, Thailand, and Malaysia supporting advanced procedures sooner than lower-income systems, where affordability and specialist availability remain key barriers.

GCC countries benefit from specialty hospital investment, medical tourism strategies, and public-sector modernization programs that can support premium ophthalmic technologies when clinical value is demonstrated. NATO countries overlap with many high-income markets where procurement standards, supply-chain resilience, cybersecurity, and regulatory compliance are increasingly relevant for AI-enabled glaucoma diagnostics, surgical planning platforms, and connected post-market data systems.

Country-Level Adoption Signals

The United States is a pivotal minimally invasive glaucoma surgery device market because of FDA pathways, Medicare-linked reimbursement, high glaucoma diagnosis volumes, and extensive ambulatory surgery center use. Canada follows evidence-based adoption through provincial health systems and specialist ophthalmology networks, while Mexico and Brazil show private-sector momentum alongside persistent access gaps in public glaucoma care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain emphasize clinical value, cost-effectiveness, safety documentation, and compliance with EU or domestic device rules. Germany and France have strong specialist infrastructure, the United Kingdom places significant weight on health technology assessment and guideline alignment, Italy and Spain combine advanced ophthalmology centers with regional reimbursement differences, and Russia remains influenced by procurement constraints, import dynamics, and geopolitical pressures.

China and India offer scale because of large aging populations and expanding eye-care infrastructure, though reimbursement, surgeon training, and affordability shape device selection. Japan prioritizes quality, safety, and clinical evidence, Australia supports specialist uptake through advanced ophthalmology networks, and South Korea combines high procedural sophistication with strong medical technology capabilities, creating favorable conditions for glaucoma imaging, surgical innovation, and post-procedure monitoring.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize rigorous comparative evidence, including intraocular pressure reduction, medication reduction, adverse events, retreatment rates, visual field stability, endothelial cell safety, and quality-of-life outcomes. Real-world registries and long-term follow-up are essential because payers, regulators, and surgeons increasingly demand durable value beyond short pivotal trials.

Commercial strategies should align device design with surgeon learning curves, procedure time, reimbursement codes, cataract workflow integration, and glaucoma severity segmentation. Organizations should also invest in AI-ready data infrastructure, physician education, market-access dossiers, health economic evidence, and region-specific pricing models for high-growth but cost-sensitive markets.

Evidence-Based Research Methodology

This executive summary is grounded in triangulated secondary research from peer-reviewed glaucoma epidemiology, public health agencies such as the World Health Organization, regulatory sources including the FDA and European authorities, ophthalmology guidelines, reimbursement information, clinical literature, and publicly available policy documents.

The analysis evaluates device categories, clinical indications, regional healthcare infrastructure, demographic demand, competitive positioning, regulatory expectations, and policy signals. Emphasis is placed on verified trends rather than speculative market claims, with qualitative interpretation anchored to documented disease burden, regulatory pathways, clinical evidence requirements, and observed adoption drivers.

Conclusion: MIGS Moves Toward Earlier, Data-Guided Care

Minimally invasive glaucoma surgery devices are becoming an important part of modern glaucoma care as clinicians seek safer, earlier, and more workflow-compatible interventions for open-angle glaucoma and cataract-associated surgical pathways. Adoption is supported by a large global glaucoma burden, aging demographics, increased diagnostic imaging use, and the need to reduce long-term dependence on topical medications.

Future leadership will depend on evidence quality, reimbursement alignment, surgeon confidence, regulatory readiness, and integration with AI-enabled diagnostics and outcomes monitoring. Device developers and healthcare stakeholders that combine clinical durability, accessible training, and region-specific market strategies will be best positioned in the evolving minimally invasive glaucoma surgery device ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Minimally Invasive Glaucoma Surgery Devices Market, by Device Type
7.1. Introduction
7.2. Ablation Tools
7.3. Catheter
7.4. Lumen-Based Shunts
7.4.1. Fixed-Lumen
7.4.2. Flow-Controlled
7.5. Scaffold/Expander
7.6. Stents
8. Minimally Invasive Glaucoma Surgery Devices Market, by Surgical Site
8.1. Introduction
8.2. Ciliary Body
8.3. Schlemm’s Canal
8.4. Subconjunctival Space
8.5. Suprachoroidal Space
8.6. Trabecular Meshwork
9. Minimally Invasive Glaucoma Surgery Devices Market, by Indication
9.1. Introduction
9.2. Angle-Closure Glaucoma
9.3. Congenital Glaucoma
9.4. Primary Open Angle Glaucoma
9.5. Secondary Glaucoma
10. Minimally Invasive Glaucoma Surgery Devices Market, by Surgical Approach
10.1. Introduction
10.2. Ab Externo
10.3. Ab Interno
11. Minimally Invasive Glaucoma Surgery Devices Market, by Procedure Type
11.1. Introduction
11.2. Combined With Cataract Surgery
11.3. Standalone Procedure
12. Minimally Invasive Glaucoma Surgery Devices Market, by Implant Material
12.1. Introduction
12.2. Metals
12.2.1. Nitinol
12.2.2. Titanium
12.3. Polymers
12.3.1. Gelatin
12.3.2. Polyethersulfone
12.3.3. Polyimide
12.3.4. Silicone
13. Minimally Invasive Glaucoma Surgery Devices Market, by Device Class
13.1. Introduction
13.2. Implantable
13.3. Non-implantable
14. Minimally Invasive Glaucoma Surgery Devices Market, by Payment Method
14.1. Introduction
14.2. Reimbursement-Based
14.3. Self-Pay
15. Minimally Invasive Glaucoma Surgery Devices Market, by Patient Type
15.1. Introduction
15.2. Pediatric
15.3. Adult
16. Minimally Invasive Glaucoma Surgery Devices Market, by Usability
16.1. Introduction
16.2. Reusable
16.3. Disposable
17. Minimally Invasive Glaucoma Surgery Devices Market, by End User
17.1. Introduction
17.2. Ambulatory Surgery Centers
17.3. Ophthalmic Clinics
17.4. Specialty Eye Hospitals
18. Minimally Invasive Glaucoma Surgery Devices Market, by Distribution Channel
18.1. Introduction
18.2. Offline
18.3. Online
19. Minimally Invasive Glaucoma Surgery Devices Market, by Region
19.1. Europe
19.2. Asia-Pacific
19.3. North America
19.4. Latin America
19.5. Middle East
19.6. Africa
20. Minimally Invasive Glaucoma Surgery Devices Market, by Group
20.1. NATO
20.2. G7
20.3. European Union
20.4. BRICS
20.5. ASEAN
20.6. GCC
21. Minimally Invasive Glaucoma Surgery Devices Market, by Country
21.1. United States
21.2. China
21.3. Germany
21.4. Japan
21.5. Canada
21.6. United Kingdom
21.7. India
21.8. Mexico
21.9. France
21.10. Italy
21.11. Brazil
21.12. South Korea
21.13. Russia
21.14. Spain
21.15. Australia
22. Competitive Landscape
22.1. Market Share Analysis, 2025
22.2. FPNV Positioning Matrix, 2025
22.3. Market Concentration Analysis, 2025
22.3.1. Concentration Ratio (CR)
22.3.2. Herfindahl Hirschman Index (HHI)
22.4. Recent Developments & Impact Analysis, 2025
22.5. Product Portfolio Analysis, 2025
22.6. Benchmarking Analysis, 2025
23. Company Profiles
23.1. AbbVie Inc.
23.2. Alcon Vision LLC
23.3. Avisi Technologies, Inc.
23.4. Bausch + Lomb Corp.
23.5. BVI Medical, Inc.
23.6. Chengdu Kanghong Pharmaceutical Group Co., Ltd.
23.7. Corza Ophthalmology Products, Inc.
23.8. Glaukos Corporation
23.9. Haag-Streit Group by Metall Zug AG
23.10. Iridex Corporation
23.11. iSTAR Medical
23.12. Johnson & Johnson Services, Inc.
23.13. Lantrek, Inc.
23.14. LIQID Medical (Pty) Ltd.
23.15. Lumenis Be Ltd.
23.16. Lumibird Medical
23.17. New World Medical, Inc.
23.18. Nova Eye Medical Limited
23.19. Oertli Instrumente AG
23.20. Rheon Medical SA
23.21. Santen Pharmaceutical Co., Ltd.
23.22. Sight Sciences, Inc.
23.23. Ziemer Ophthalmic Systems AG
List of Figures
FIGURE 1. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
FIGURE 23. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 27. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 29. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 33. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 35. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 37. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ABLATION TOOLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ABLATION TOOLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ABLATION TOOLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CATHETER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CATHETER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CATHETER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LUMEN-BASED SHUNTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LUMEN-BASED SHUNTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LUMEN-BASED SHUNTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL FIXED-LUMEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL FIXED-LUMEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL FIXED-LUMEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL FLOW-CONTROLLED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FLOW-CONTROLLED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FLOW-CONTROLLED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SCAFFOLD/EXPANDER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SCAFFOLD/EXPANDER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SCAFFOLD/EXPANDER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CILIARY BODY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CILIARY BODY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CILIARY BODY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SCHLEMM’S CANAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SCHLEMM’S CANAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SCHLEMM’S CANAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SUBCONJUNCTIVAL SPACE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SUBCONJUNCTIVAL SPACE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SUBCONJUNCTIVAL SPACE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SUPRACHOROIDAL SPACE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SUPRACHOROIDAL SPACE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SUPRACHOROIDAL SPACE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL TRABECULAR MESHWORK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL TRABECULAR MESHWORK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL TRABECULAR MESHWORK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ANGLE-CLOSURE GLAUCOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ANGLE-CLOSURE GLAUCOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ANGLE-CLOSURE GLAUCOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CONGENITAL GLAUCOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CONGENITAL GLAUCOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CONGENITAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PRIMARY OPEN ANGLE GLAUCOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PRIMARY OPEN ANGLE GLAUCOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PRIMARY OPEN ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SECONDARY GLAUCOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL SECONDARY GLAUCOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL SECONDARY GLAUCOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL AB EXTERNO MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL AB EXTERNO MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL AB EXTERNO MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL AB INTERNO MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL AB INTERNO MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL AB INTERNO MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL COMBINED WITH CATARACT SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL COMBINED WITH CATARACT SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL COMBINED WITH CATARACT SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL STANDALONE PROCEDURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL STANDALONE PROCEDURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL STANDALONE PROCEDURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL METALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL METALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL METALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL NITINOL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL NITINOL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL NITINOL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL TITANIUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL TITANIUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL TITANIUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL GELATIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL GELATIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL GELATIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL POLYETHERSULFONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL POLYETHERSULFONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL POLYETHERSULFONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL POLYIMIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL POLYIMIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL POLYIMIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL SILICONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL SILICONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL SILICONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL IMPLANTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL IMPLANTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL IMPLANTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL NON-IMPLANTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL NON-IMPLANTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL NON-IMPLANTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL REIMBURSEMENT-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL REIMBURSEMENT-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL REIMBURSEMENT-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL SELF-PAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL SELF-PAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL SELF-PAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL REUSABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL REUSABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL REUSABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL DISPOSABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL DISPOSABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL DISPOSABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL SPECIALTY EYE HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL SPECIALTY EYE HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL SPECIALTY EYE HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 141. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 142. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 143. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 144. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 145. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 146. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 147. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 148. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 149. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 150. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 151. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 152. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 153. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 154. EUROPE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 183. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 184. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 185. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 186. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 196. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 197. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 198. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 199. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 200. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 201. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. LATIN AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 206. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 207. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 208. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 209. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 213. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 214. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 215. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 216. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 217. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 219. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 220. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 221. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 222. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 223. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 224. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 225. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 226. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 227. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 228. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 229. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 230. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 231. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 232. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 233. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 235. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 236. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 238. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 239. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 240. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 241. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 242. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 243. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 244. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 245. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 246. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 247. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 248. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 249. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 250. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. NATO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 252. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 253. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 254. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 255. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 256. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 257. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 258. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 259. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 260. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 261. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 262. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 263. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 264. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 265. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 266. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 267. G7 MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 284. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 285. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 286. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 287. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 288. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 289. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 290. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 291. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 292. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 293. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 294. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 295. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 296. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 297. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 298. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. BRICS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 300. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 301. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 302. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LUMEN-BASED SHUNTS, 2017-2032 (USD MILLION)
TABLE 303. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL SITE, 2017-2032 (USD MILLION)
TABLE 304. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 305. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 306. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 307. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY IMPLANT MATERIAL, 2017-2032 (USD MILLION)
TABLE 308. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 309. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY POLYMERS, 2017-2032 (USD MILLION)
TABLE 310. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 311. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PAYMENT METHOD, 2017-2032 (USD MILLION)
TABLE 312. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 313. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY USABILITY, 2017-2032 (USD MILLION)
TABLE 314. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 315. ASEAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 316. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 317. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 318. GCC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SI

Companies Mentioned

  • AbbVie Inc.
  • Alcon Vision LLC
  • Avisi Technologies, Inc.
  • Bausch + Lomb Corp.
  • BVI Medical, Inc.
  • Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  • Corza Ophthalmology Products, Inc.
  • Glaukos Corporation
  • Haag-Streit Group by Metall Zug AG
  • Iridex Corporation
  • iSTAR Medical
  • Johnson & Johnson Services, Inc.
  • Lantrek, Inc.
  • LIQID Medical (Pty) Ltd.
  • Lumenis Be Ltd.
  • Lumibird Medical
  • New World Medical, Inc.
  • Nova Eye Medical Limited
  • Oertli Instrumente AG
  • Rheon Medical SA
  • Santen Pharmaceutical Co., Ltd.
  • Sight Sciences, Inc.
  • Ziemer Ophthalmic Systems AG

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 671.86 Million
Forecasted Market Value ( USD ) by 2032 $ 944.8 Million
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Glaucoma Surgery Devices Market - Global Forecast 2026-2032 - Product Image

Glaucoma Surgery Devices Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Glaucoma Treatment Market - Global Forecast 2026-2032 - Product Image

Glaucoma Treatment Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Glaucoma Surgery Devices - Global Strategic Business Report - Product Image

Glaucoma Surgery Devices - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report 2026 - Product Image

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Glaucoma Surgery Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035) - Product Image

Glaucoma Surgery Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • 400 Pages
  • Global
From

About the Minimally Invasive Glaucoma Surgery Devices Market

Minimally Invasive Glaucoma Surgery (MIGS) devices are a subset of surgical devices designed for the treatment of glaucoma, a chronic eye condition that leads to increased intraocular pressure (IOP) and can result in vision loss. These devices offer a less invasive alternative to traditional glaucoma surgeries, aiming to reduce IOP by improving aqueous humor outflow from the eye. MIGS procedures typically involve micro-scale incisions and implants, promising reduced recovery times and a lower risk of complications compared to conventional surgical methods. The market for MIGS devices overlaps with the broader ophthalmic surgical device market and aligns with an increasing demand for surgeries that provide symptom relief while minimizing tissue trauma. The development and adoption of MIGS devices have been influenced by technological advances, the rising prevalence of glaucoma, and the prioritization of patient quality of life and surgical outcomes. As a niche within surgical devices, MIGS products often require specialized training for surgeons and are accompanied by ongoing research and development to optimize their efficacy and safety profiles. In the market for MIGS devices, several companies are prominent, including Glaukos Corporation, Ivantis Inc., Alcon, a division of Novartis, and Johnson & Johnson Vision, a subsidiary of Johnson & Johnson. Other players include Allergan (now part of AbbVie), and New World Medical, which also contribute to the research, development, and distribution of these specialized surgical instruments for gl Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.